1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Global Influenza Market - Vaccines and Therapeutics

Global Influenza Market - Vaccines and Therapeutics

  • March 2016
  • -
  • Industry Experts
  • -
  • 128 pages

Summary

Table of Contents

The influenza virus has been implicated in infecting millions of individuals on an annual basis, with vaccination programs against seasonal influenza infections necessitating the manufacture of hundreds of million doses within a very short time period. The emergence of innovative production systems based on mammalian or insect cell cultures have resulted in surmount the hurdles associated with the egg-based production system. These industrially well-established production systems provide a faster and more flexible response to pandemic threats.

The existing range of influenza vaccines are produced in fertilized eggs, the embryo of which is infected in order that the virus can proliferate. Following a period of incubation, the virus is harvested and purified. This system of production is complicated and lacking in the event of a pandemic due to the possibility of generating low yields, not being amenable to rapid scale-up and being dependent on the availability of eggs. Global authorities have acknowledged problems associated with manufacturing vaccines based on eggs, resulting in creating a need for developing alternative vaccine production systems. The current scenario has been focusing on the development of manufacturing systems based on plants, bacteria, yeast and cell cultures.

Worldwide market for Influenza Vaccines is analyzed in both volumes in doses and value in USD for the period from 2012 through to 2022. The market for influenza therapeutics is analyzed in terms of value only at a global level. The global market for overall influenza is estimated to be US$6.1 billion in 2016 and anticipated to reach US$10.2 billion by 2022, witnessing a robust 8.5% CAGR between 2016 and 2022. Vaccines account for about 80% of the influenza market while therapeutics account for the remaining. However, therapeutics segment is projected to be the fastest growing with a CAGR of 11% during the aforementioned analysis period.

The report reviews, analyses and projects the Influenza therapeutics market at the global level while vaccines market is explored in and the regional markets including North America, Europe, Asia-Pacific, South & Central America and Middle East & Africa.

This 128 page market research report includes 30 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. This report profiles 16 key global players and 39 major players across North America – 8; Europe – 10; Asia-Pacific – 20 and South & Central America – 1. The research also provides the listing of the companies engaged in research and development, manufacturing and supply of influenza vaccines and therapeutic. The global list of companies covers addresses, contact numbers and the website addresses of 80 companies.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Influenza Diagnostics Market by Test type, Molecular, End user - Global Forecast to 2021

Influenza Diagnostics Market by Test type, Molecular, End user - Global Forecast to 2021

  • $ 5650
  • Industry report
  • February 2017
  • by MarketsandMarkets

The global influenza diagnostics market is expected to reach USD 767.4 million by 2021 from USD 508.0 million in 2016, at a CAGR of 8.6% from 2016 to 2021. On the basis of test type, the market is segmented ...

Seasonal Influenza Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Elderly Population, Growing Awareness and Launch of Quadrivalent Therapies

Seasonal Influenza Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Elderly Population, Growing Awareness and Launch of Quadrivalent Therapies

  • $ 4995
  • Industry report
  • January 2017
  • by GBI Research

Seasonal Influenza Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Elderly Population, Growing Awareness and Launch of Quadrivalent Therapies Summary Influenza, often referred to ...

H1N1 (Swine Influenza)- Market Insights, Epidemiology and Market Forecast-2023

H1N1 (Swine Influenza)- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • March 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s H1N1 (Swine Influenza) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...


Download Unlimited Documents from Trusted Public Sources

Influenza Statistics and Diabetes Statistics in India

  • March 2017
    6 pages
  • Influenza  

    Diabetes  

    Hospital  

  • India  

    United States  

View report >

Influenza Statistics in Ireland, Weekly Update

  • March 2017
    12 pages
  • Influenza  

  • Ireland  

    Europe  

View report >

Influenza Statistics in the UK, Weekly Update

  • March 2017
    11 pages
  • Influenza  

  • United Kingdom  

    Europe  

View report >

Related Market Segments :

Influenza

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.